Maftivimab Antibody
Maftivimab (REGN3470-3471-3479), also known as Inmazeb, is an FDA-approved monoclonal antibody cocktail targeting the Zaire ebolavirus. It functions as a filovirus inhibitor and is applied in research for studying Ebola virus infection mechanisms, supported by in vitro neutralization and in vivo non-human primate efficacy studies.
Product Specifications
Target
Virus Protease
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
39377066 1.0 µg DNA
RGD1564804 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 
A06672-1-Fluoro488 100 µg/Vial
Anti-STRN3 Antibody Picoband® Fluoro488 Conjugated
Sign In for Pricing
View Details 